deltatrials
Unknown PHASE2 NCT00411853

Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

An Open Phase II Clinical Trial of Fermented Wheat Germ Extract in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

Sponsor: Sheba Medical Center

Conditions Hormone Refractory Prostate Cancer
Interventions Fermented Wheat germ extract
Updated 6 times since 2017 Last updated: Jul 30, 2009 Started: Jun 30, 2007 Primary completion: Jun 30, 2011 Completion: Jun 30, 2012

A PHASE2 clinical study on Hormone Refractory Prostate Cancer, this trial is ongoing. The trial is conducted by Sheba Medical Center and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sheba Medical Center
Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tel Litwinsky, Israel